E
Bellerophon Therapeutics, Inc. BLPH
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Weiss Ratings BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Weak
Risk Grade D-
Reward Grade E
Rating Factors BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Fair
Efficiency Index Very Weak
Solvency Index Good
Total Return Index Very Weak
Volatility Index Weak
Beta / Standard Deviation BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.03
Price History BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -9.52%
30-Day Total Return -48.65%
60-Day Total Return -47.22%
90-Day Total Return -45.71%
Year to Date Total Return -48.65%
1-Year Total Return -41.18%
2-Year Total Return -97.65%
3-Year Total Return -99.27%
5-Year Total Return -99.63%
52-Week High % Change -88.00%
52-Week Low % Change 20.00%
Price BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $0.10
52-Week Low Price $0.01
52-Week Low Price (Date) Dec 11, 2024
52-Week High Price (Date) Oct 23, 2024
Valuation BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 232.42K
Enterprise Value -4.15M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.84
Earnings Per Share Growth -58.04%
Price/Earnings To Growth --
Price/Sales (TTM) 0.04
Price/Book (Q) 0.06
Enterprise Value/Revenue (TTM) -0.69
Price $0.02
Enterprise Value/EBITDA (TTM) 0.35
Enterprise Value/EBIT 0.35
Market Cap Category Nano Cap
Dividends and Shares BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 12.23M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 908 574 4770
Address 20 Independence Boulevard Warren, NJ 07059
Website bellerophon.com
Country United States
Year Founded 2009
Profitability BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) -195.65%
Profit Margin -164.06%
Management Effectiveness BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets -78.43%
Return on Equity --
Income Statement BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 5.64M
Total Revenue (TTM) 5.64M
Revenue Per Share $0.46
Gross Profit (TTM) 5.64M
EBITDA (TTM) -11.03M
EBIT (TTM) -11.04M
Net Income (TTM) -9.25M
Net Income Avl. to Common (TTM) -9.25M
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 62.10%
EPS Diluted (TTM) -0.84
EPS Diluted Growth (Q YOY) 69.87%
Balance Sheet BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 4.38M
Cash Per Share (Q) $0.36
Total Current Assets (Q) 4.98M
Total Preferred Equity (Q) --
Total Equity (Q) 3.72M
Current Ratio (Q) 3.964
Book Value Per Share (Q) $0.30
Total Assets (Q) 4.98M
Total Current Liabilities (Q) 1.26M
Total Debt (Q) 0.00
Total Liabilities (Q) 1.26M
Total Common Equity (Q) 3.72M
Cash Flow BLPH - OTC PK Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) 140.00K
Cash from Financing (TTM) 4.97M
Net Change in Cash (TTM) -7.23M
Levered Free Cash Flow (TTM) -9.69M
Cash from Operations (TTM) -12.34M
Weiss Ratings